Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception20231130144754
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception
November 30, 20230 comments
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception Orlando, FL, November 30, 2023 (...
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception20231130144636
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception
November 30, 20230 comments
Orlando, FL, Nov. 30, 2023 — Biostax Corp., (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development engine, proudly announ...
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro20231115143241
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
November 15, 20230 comments
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro Orlando, FL, November 15, 2023 (GLOBE NEWSWIRE) — Biostax Corp (OTC...
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors20231102141249
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
November 2, 20230 comments
Orlando, FL, Nov. 02, 2023 — Biostax Corp (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development engine, announces the ap...
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors20231102135413
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
November 2, 20230 comments
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors Orlando, FL, November. 2, 2023 (GLOBE NEWSWIRE) — Biostax Corp (...
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment20231024131722
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
October 24, 20230 comments
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Tr...
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment20231024131648
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
October 24, 20230 comments
ORLANDO, Fla., Oct. 24, 2023 — Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solutions, today announced a m...
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky20230914132140
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky
September 14, 20230 comments
Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) — Immune Therapeutics,...
Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV20230829133319
Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV
August 29, 20230 comments
Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) — Immun...
Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH20230815131650
Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH
August 15, 20230 comments
Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD...